DNA vaccines induce partial protection against Leishmania mexicana

被引:47
作者
Dumonteil, E
Jesus, RSM
Javier, EO
del Rosario, GMM
机构
[1] Univ Autonoma Yucatan, CIR Dr Hideyo Noguchi, Parasitol Lab, Merida 97000, Yucatan, Venezuela
[2] Univ Autonoma Yucatan, CIR Dr Hideyo Noguchi, Lab Inmunobiol CIR, Merida 97000, Yucatan, Venezuela
关键词
Leishmania mexicana; DNA vaccines; partial protection;
D O I
10.1016/S0264-410X(02)00769-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As part of an ongoing effort to develop a vaccine against Leishmania mexicana, we tested DNA vaccines encoding L mexicana GP63, CPb, and LACK, and L. amazonensis GP46, to evaluate this strategy and define the best antigen candidates. Immune responses and vaccine efficacy were evaluated in BALB/c mice immunized with plasmid DNA encoding the different antigens. All four DNA vaccines induced Leishmania-specific humoral and lympho-proliferative immune responses. However, only mice immunized with VR1012-GP46, VR1012-GP63 and VR1012-CPb were partially protected against infection, as evidenced by reduced lesion size and parasite burden. Interestingly, immunization of mice with a mixture of these three plasmids further increased protection. Thus, plasmids encoding CPb, GP63 and GP46 represent good candidates for further development of DNA vaccines against L. mexicana. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2161 / 2168
页数:8
相关论文
共 42 条
  • [31] ISCOMs vaccine against experimental leishmaniasis
    Papadopoulou, G
    Karagouni, E
    Dotsika, E
    [J]. VACCINE, 1998, 16 (9-10) : 885 - 892
  • [32] Vaccination of BALB/c mice with Leishmania major amastigote-specific cysteine proteinase
    Rafati, S
    Baba, AA
    Bakhshayesh, M
    Vafa, M
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01) : 134 - 138
  • [33] A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
    Rafati, S
    Salmanian, AH
    Taheri, T
    Vafa, M
    Fasel, N
    [J]. VACCINE, 2001, 19 (25-26) : 3369 - 3375
  • [34] Vaccines against intracellular infections requiring cellular immunity
    Seder, RA
    Hill, AVS
    [J]. NATURE, 2000, 406 (6797) : 793 - 798
  • [35] Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran
    Sharifi, I
    FeKri, AR
    Aflatonian, MR
    Khamesipour, A
    Nadim, A
    Mousavi, MRA
    Momeni, AZ
    Dowlati, Y
    Godal, T
    Zicker, F
    Smith, PG
    Modabber, F
    [J]. LANCET, 1998, 351 (9115) : 1540 - 1543
  • [36] Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection
    Sjölander, A
    Baldwin, TM
    Curtis, JM
    Bengtsson, KL
    Handman, E
    [J]. VACCINE, 1998, 16 (20) : 2077 - 2084
  • [37] Sjölander A, 1998, J IMMUNOL, V160, P3949
  • [38] T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana
    Torrentera, FA
    Glaichenhaus, N
    Laman, JD
    Carlier, Y
    [J]. INFECTION AND IMMUNITY, 2001, 69 (01) : 617 - 621
  • [39] Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis
    Walker, PS
    Scharton-Kersten, T
    Rowton, ED
    Hengge, U
    Bouloc, A
    Udey, MC
    Vogel, JC
    [J]. HUMAN GENE THERAPY, 1998, 9 (13) : 1899 - 1907
  • [40] XU D, 1995, IMMUNOLOGY, V85, P1